RETROVIR (ViiV Healthcare Company)
Welcome to the PulseAid listing for the RETROVIR drug offered from ViiV Healthcare Company. This Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | ViiV Healthcare Company |
| NON-PROPRIETARY NAME: | zidovudine |
| SUBSTANCE NAME: | ZIDOVUDINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2010-10-28 |
| END MARKETING DATE: | 0000-00-00 |
RETROVIR HUMAN PRESCRIPTION DRUG Details:
| Item Description | RETROVIR from ViiV Healthcare Company |
| LABELER NAME: | ViiV Healthcare Company |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100(mg/1) |
| START MARKETING DATE: | 2010-10-28 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 49702-211_eb326b34-f770-4523-ac6d-661bc173f256 |
| PRODUCT NDC: | 49702-211 |
| APPLICATION NUMBER: | NDA019655 |
Other ZIDOVUDINE Pharmaceutical Manufacturers / Labelers:
